Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study-Reference-Cited by-同舟云学术

Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study

Published:2019-06 Issue:6 Volume:4 Page:445-453
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Trauner Michael,Nevens Frederik,Shiffman Mitchell L,Drenth Joost P H,Bowlus Christopher L,Vargas Victor,Andreone Pietro,Hirschfield Gideon M,Pencek Richard,Malecha Elizabeth Smoot,MacConell Leigh,Shapiro David

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases;Lindor;Hepatology,2018

2. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis;J Hepatol,2017

3. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study;Lammers;Gastroenterology,2014

4. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid;Carbone;Gastroenterology,2013

5. New developments in the treatment of primary biliary cholangitis − role of obeticholic acid;Jhaveri;Ther Clin Risk Manag,2017

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NTCP for liver disease treatment: A promising strategy;Journal of Pharmaceutical Analysis;2024-09

2. The gut microbiota-bile acid axis in cholestatic liver disease;Molecular Medicine;2024-07-19

3. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy;JHEP Reports;2024-07

4. Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions;Frontiers in Microbiology;2024-06-03

5. Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective;Gastroenterology Insights;2024-05-17